Understanding how CD8 T cells respond to SARS-CoV-2 and their role in Long COVID
Elucidating the lineage dynamics of optimal human CD8 T cell responses to SARS-CoV-2 and how CD8 T cell homeostasis is altered in Long COVID
This study is looking at how certain immune cells called CD8 T cells work to fight off COVID-19, especially in people who have lingering symptoms, to help find ways to improve vaccines and treatments for the virus and its long-term effects.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11083549 on NIH RePORTER |
What this research studies
This research investigates the behavior of CD8 T cells, which are crucial for fighting viral infections like COVID-19. It aims to understand how these immune cells differentiate and respond to the virus, especially in individuals who experience Long COVID symptoms. By analyzing blood samples and immune responses, the study seeks to identify the factors that lead to effective or dysfunctional T cell responses. This knowledge could help in developing better vaccines and treatments for COVID-19 and its long-term effects.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have had COVID-19, especially those experiencing Long COVID symptoms.
Not a fit: Patients who have not been infected with SARS-CoV-2 or do not exhibit any symptoms related to COVID-19 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and therapies for COVID-19 and Long COVID, enhancing patient recovery and quality of life.
How similar studies have performed: Other research has shown promise in understanding T cell responses to viral infections, indicating that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Painter, Mark M — University of Pennsylvania
- Study coordinator: Painter, Mark M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.